-+ 0.00%
-+ 0.00%
-+ 0.00%

Preview: Summit Therapeutics's Earnings

Benzinga·02/20/2026 14:02:18
Listen to the news

Summit Therapeutics (NASDAQ:SMMT) will release its quarterly earnings report on Monday, 2026-02-23. Here's a brief overview for investors ahead of the announcement.

Analysts anticipate Summit Therapeutics to report an earnings per share (EPS) of $-0.11.

Investors in Summit Therapeutics are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.

It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.

Historical Earnings Performance

In the previous earnings release, the company missed EPS by $0.05, leading to a 6.46% drop in the share price the following trading session.

Here's a look at Summit Therapeutics's past performance and the resulting price change:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate -0.08 -0.08 -0.09 -0.08
EPS Actual -0.13 -0.12 -0.07 -0.07
Price Change % -6.00 -9.00 13.00 -4.00

eps graph

Market Performance of Summit Therapeutics's Stock

Shares of Summit Therapeutics were trading at $15.87 as of February 19. Over the last 52-week period, shares are down 15.76%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for Summit Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.